2BB score and signals
Immix Biopharma, Inc.’s current 2BB score is 35 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 59 | Moderate |
| Momentum | 30 | Weakening |
| Financial strength | 30 | Weak |
| Quality | 40 | Normal |
| Risk | 39 | Low |
Company facts
| Headquarters | Los Angeles, California, United States |
| Founded | 2012 |
| Employees | 21 |
| 52-week range | $1.94 – $12.14 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-05 | — | -0.2009 | — | $0.00 |
| 2026-08-06 | — | -0.1792 | — | $0.00 |
| 2026-05-07 | -0.18 | -0.2124 | $0.00 | $0.00 |
| 2026-03-25 | -0.28 | -0.1591 | $0.00 | $0.00 |
Related companies
